ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Astellas Pharma Inc

Astellas Pharma Inc (YPH)

9,57
0,242
( 2,59% )
Aktualisiert: 17:42:33
Echtzeitdaten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
9,57
Gebot
9,378
Fragen
9,57
Volumen
435
9,42 Tagesbereich 9,57
8,454 52-Wochen-Bereich 12,00
Handelsende
9,328
Handelsbeginn
9,42
Letzte Trade
200
@
9.57
Letzter Handelszeitpunkt
10:51:16
Durchschnittliches Volumen (3 Mio.)
1.483
Finanzvolumen
-
VWAP
-

YPH Neueste Nachrichten

Takeda, Astellas and Sumitomo to create new drug discovery company

Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc and Sumitomo Mitsui Financial Group Inc on Monday agreed to establi ...

IN BRIEF: Astellas receives FDA exclusivity approval for Cresemba

nc - Tokyo-based pharmaceutical company - Receives orphan drug and pediatric exclusivity approval from the US Food & D ...

Merck and Astellas drugs get priority review in US and Japan

Merck & Co Inc announced on Tuesday that its cancer treatment Keytruda with chemotherapy has been granted priority re ...

Astellas and Pfizer's Padcev validated by EMA to treat bladder cancer

Pfizer Inc and Astellas Pharma Inc on Friday celebrated the European Medicines Agency's decision to validate its appl ...

Astellas, Merck, Pfizer celebrate US approval for Keytruda plus Padcev

Astellas Pharma Inc, Merck & Co Inc and Pfizer Inc on Friday announced expanded approval in the US for Keytruda combi ...

IN BRIEF: Astellas Pharma announces US FDA green light for Cresemba

nc - Tokyo-based pharmaceutical company - Says the US Food & Drug Administration has approved Cresemba, an azole antif ...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.4685.141727092959.1029.578.928729.01178905DE
40.1161.226993865039.4549.69999998.927299.20170886DE
12-0.975-9.2460881934610.545128.9214839.71096485DE
26-0.565-5.5747409965510.135128.92150610.38236095DE
52-1.075-10.098637858110.645128.45415829.81166642DE
156-4.495-31.958762886614.06514.48.454157310.21304304DE
260-4.495-31.958762886614.06514.48.454157310.21304304DE

YPH - Frequently Asked Questions (FAQ)

What is the current Astellas Pharma share price?
The current share price of Astellas Pharma is 9,57 €
What is the 1 year trading range for Astellas Pharma share price?
Astellas Pharma has traded in the range of 8,454 € to 12,00 € during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
H9WHwa Ag
3,70 €
(66,67%)
20,12k
0PV2Moovly Media Inc
0,007 €
(55,56%)
650
N8TGenerative AI Solutions Corp
0,16 €
(39,13%)
11k
IFGAAtari SA
0,1625 €
(31,05%)
1,17M
VJ3Troy Minerals Inc
0,115 €
(30,68%)
287,93k
5MCLeap Therapeutics Inc
0,62 €
(-71,03%)
7,61k
WWTWater Ways Technologies Inc
0,002 €
(-60,00%)
180k
1UR1Bee Vectoring Technologies International Inc
0,003 €
(-40,00%)
17k
LL3PanGenomic Health Inc
0,1401 €
(-36,23%)
161
OU5AAvalon Advanced Materials Inc
0,0142 €
(-34,86%)
206,52k
D7GNel ASA
0,1994 €
(6,63%)
7,1M
3MWLivium Ltd
0,0088 €
(-12,00%)
2,17M
NVDNVIDIA Corp
116,56 €
(3,15%)
1,94M
3CPXiaomi Corporation
4,8375 €
(5,52%)
1,69M
IFGAAtari SA
0,1625 €
(31,05%)
1,17M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht